Vollbach et al. have shown that human polymorphisms in the promoter region of the APOA1 gene (−75 A/G) are associated with early AD pathogenesis; individuals homozygous for the A allele of ApoA1 develop AD approximately 8 years faster than heterozygotes [109,110]. This evidence concerns the gene APOA1 and Alzheimer disease.